Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism AGER antagonists(Advanced glycosylation end product-specific receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | - | 30 Mar 2023 |